Anticoagulant activity of a naphthoquinone analog of vitamin K and an inhibitor of coenzyme Q10- enzyme systems.

No abstract is available for this paper.

• Publication year

  1976

• Venue

  Research communications in chemical pathology and pharmacology

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  PMID 1257593
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Study of periodontal disease and coenzyme Q.

  1975cited by this paper
• Bioenergetics in clinical medicine. Studies on coenzyme Q10 and essential hypertension.

  1975cited by this paper
• Postribosomal function of vitamin K in prothrombin synthesis.

  1974cited by this paper
• Effect of coenzyme Q10 on experimental hypertension in rats and dogs.

  1974cited by this paper
• Antimetabolites of coenzyme Q. 16. New alkylmercaptoquinones having antimalarial curative activity.

  1973cited by this paper
• Mechanism of Action of Vitamin K: Demonstration of a Liver Precursor of Prothrombin

  1973cited by this paper
• Anticoagulant-Resistant Rats: Possible Control by the Use of the Chloro Analog of Vitamin K1

  1973cited by this paper
• Deficiency of coenzyme Q 10 in a succinate-CoQ 10 -Enzyme in the dystrophic rabbit on an antioxidant deficient diet.

  1972cited by this paper
• Warfarin and the Inhibition of Vitamin K Activity by an Oxide Metabolite

  1972cited by this paper
• Survey and new clinical studies on conenzyme Q in human muscular dystrophy.

  1972cited by this paper
• Survey on the vitamin aspects of coenzyme Q.

  1969cited by this paper
• A Hemorrhagic Syndrome Induced by Derivatives of 3-Hydroxy-1, 4-Naphthoquinone.∗

  1946cited by this paper

• Pharmacologic interventions targeting ovarian aging, cancer, and mitochondrial dysfunction: An updated evidence.

  2025cites this paper
• Potential Drug–Nutrient Interactions of 45 Vitamins, Minerals, Trace Elements, and Associated Dietary Compounds with Acetylsalicylic Acid and Warfarin—A Review of the Literature

  2024cites this paper
• The influence of age, vitamin K and genetics on anticoagulation outcomes in adults and children

  2019influential citation
• Dietary implications for patients receiving long-term oral anticoagulation therapy for treatment and prevention of thromboembolic disease

  2017cites this paper
• Coenzyme Q10 and Heart Failure: A State-of-the-Art Review

  2016cites this paper
• Novel Algicidal Substance (Naphthoquinone Group) from Bio-derived Synthetic Materials against Harmful Cyanobacteria, Microcystis and Dolichospermum

  2016cites this paper
• Integrative Therapies for People with Interstitial Lung Disease, Idiopathic Pulmonary Fibrosis, and Pulmonary Arterial Hypertension

  2012cites this paper
• Diffuse Large Cell Lymphoma Presenting as a Sacral Mass and Lupus Anticoagulant

  2011cites this paper
• Subchronic Oral Toxicity of Ubiquinol in Rats and Dogs

  2008cites this paper
• Complementary and alternative medicine in cardiovascular disease: a review of biologically based approaches.

  2004cites this paper
• Update on natural product--drug interactions.

  2002cites this paper
• Interactions between Warfarin and Herbal Products, Minerals, and Vitamins: A Pharmacist's Guide

  2001cites this paper
• Effect of Ubidecarenone on Warfarin Anticoagulation and Pharmacokinetics of Warfarin Enantiomers in Rats

  2001cites this paper
• Potential interactions between alternative therapies and warfarin.

  2000cites this paper
• Warfarin Potential interactions between alternative therapies and warfarin

  2000cites this paper
• Haemorrhagic toxicity of a large dose of α-, β-, γ- and δ-tocopherols, ubiquinone, β-carotene, retinol acetate and L-ascorbic acid in the rat

  1995cites this paper
• Haemorrhagic toxicity of a large dose of alpha-, beta-, gamma- and delta-tocopherols, ubiquinone, beta-carotene, retinol acetate and L-ascorbic acid in the rat.

  1995cites this paper
• Reduced effect of warfarin caused by ubidecarenone.

  1994cites this paper
• Lapachol inhibition of vitamin K epoxide reductase and vitamin K quinone reductase.

  1984cites this paper